, Taiwan
/Photo from Raysearch Labs

Treatment planning system to be installed at Taiwan smart hospital

Taichung Veterans General Hospital will use a Sumitomo proton therapy machine.

Taichung Veterans General Hospital (TVGH) will soon get a treatment planning system from photon therapy machine vendor for the fast delivery of plans involving the treatment of moving tumors.

RaySearch Laboratories AB (publ) announced this in a press release, saying that Sumitomo Corporate has placed an order for RayStation®* treatment planning system to install the system at TVGH.

The order has licenses for both proton and photon treatment and advanced functionality such as Multi Criteria Optimization (MCO) and dose calculation on CBCT images for proton treatment.

TVGH will use a Sumitomo proton therapy machine with Sumitomo's compact next-generation system, to which RayStation will be adapted. 

The delivery of the device is expected in 2025 and will be used to improve patient outcomes.
 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Saudi’s KFSHRC banks on innovation to transform healthcare
The hospital is accelerating adoption of emerging technologies to position itself as a global leader in medicine
Angkor Hospital eyes trauma centre for children
The facility will have an ICU, emergency room, operating theatre and a surgical ward.